Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 17, 2005Pediatric Transplantation

Current approaches to treatment of antibody‐mediated rejection

View Full Paper
Ask AI
Bookmark
Share

Authors

SJStanley C. JordanCedars-Sinai Medical CenterAVAshley VoCedars-Sinai Medical CenterDTDolly B. TyanPalo Alto University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Jordan et al. (2005) studied this question.

synapsesocial.com/papers/6a92c72dfa60aefc093ad56ahttps://doi.org/10.1111/j.1399-3046.2005.00363.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Intravenous immunoglobulin prevents experimental autoimmune myositis in SJL mice by reducing anti-myosin antibody and by blocking complement deposition2001 · 34 citations
  2. 2Anti-inflammatory Activity of IVIG Mediated Through the Inhibitory Fc Receptor2001 · 1,056 citations
  3. 3Significance of the Positive Crossmatch Test in Kidney Transplantation1969 · 1,514 citations
  4. 4A RANDOMIZED AND PROSPECTIVE STUDY COMPARING TREATMENT WITH HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN WITH MONOCLONAL ANTIBODIES FOR RESCUE OF KIDNEY GRAFTS WITH STEROID-RESISTANT REJECTION2001 · 141 citations